中國華融(02799.HK)完成發行內資股和H股 籌得約420億元
格隆匯12月30日丨中國華融(02799.HK)宣佈,載於公吿及補充通函中有關此次發行和股份認購協議的所有先決條件均已獲達成(其中包括公司已就此次發行的相關事項獲得中國銀保監會、中國證監會批准及香港聯交所對發行H股的上市批准),且此次發行內資股和此次發行H股已於2021年12月30日完成。
根據此次發行方案,合共39,215,686,272股內資股已於2021年12月30日分別發行予中信集團(18,823,529,411股)、中保融信基金(14,509,803,921股)、中國信達(3,921,568,627股)和工銀投資(1,960,784,313股);合共1,960,784,313股H股已於2021年12月30日發行予中國人壽。據此,緊隨此次發行內資股和此次發行H股完成後,公司股份總額增加至80,246,679,047股,包括53,242,041,816股內資股及27,004,637,231股H股。
此次發行募集的資金總額為人民幣41,999,999,996.7元,在扣除相關發行費用後將全部用於補充公司核心一級資本。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.